Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 13/20 | 0.46 |
| ▸ | CCR3 | P51677 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TACR2 | P21452 | 3/20 | 0.38 |
| ▸ | TACR3 | P29371 | 1/20 | 0.38 |
| ▸ | RHOC | P08134 | 1/20 | 0.37 |
| ▸ | RHOA | P61586 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3080781 | 1.00 | TACR1 (0.46) | TACR1CCR3KDM4EALDH1A1MAPT | |
| SCHEMBL3222410 | 0.87 | TACR1 (0.45) | TACR1CCR3TACR2RHOCRHOA | |
| SCHEMBL3222415 | 0.87 | TACR1 (0.45) | TACR1CCR3TACR2RHOCRHOA | |
| SCHEMBL3086886 | 0.87 | TACR1 (0.50) | TACR1CCR3TACR2TACR3 | |
| SCHEMBL3086889 | 0.87 | TACR1 (0.50) | TACR1CCR3TACR2TACR3 | |
| SCHEMBL3208966 | 0.86 | TACR1 (0.49) | TACR1CCR3KDM4EALDH1A1TACR2 | |
| SCHEMBL3212277 | 0.86 | TACR1 (0.49) | TACR1CCR3KDM4EALDH1A1TACR2 | |
| SCHEMBL3208973 | 0.86 | TACR1 (0.49) | TACR1CCR3KDM4EALDH1A1TACR2 | |
| SCHEMBL3088212 | 0.86 | TACR1 (0.49) | TACR1CCR3TACR2TACR3RHOC | |
| SCHEMBL12809224 | 0.86 | TACR1 (0.49) | TACR1CCR3TACR2TACR3RHOC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1581518-B1 | SUBSTITUTED 1-PIPERIDIN-4-YL-4-PYRROLIDIN-3-YL-PIPERAZINE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2011-03-02 | — | — | EP | disclosed |